Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT01453920
Eligibility Criteria:
Inclusion Criteria:
* Age 50 years or more
* Active primary or recurrent choroidal neovascularization secondary to AMD in the study eye, currently stable on an 'every three month' treatment regimen (established using a treat and extend dosing protocol)
* Best-corrected visual acuity of Counting Fingers or better (Snellen equivalent) in the study eye
* All IVFA lesion types and lesion sizes
* One eye per subject (the "study eye"). If both eyes are eligible, the one with better VA will be selected unless, for medical reasons, the other is more appropriate
Exclusion Criteria:
* Treatment of the current choroidal neovascular membrane with verteporfin photodynamic therapy (PDT), external-beam radiation therapy, transpupillary thermotherapy, or subfoveal laser photocoagulation (or juxtafoveal or extrafoveal laser photocoagulation
* History of vitrectomy surgery in the study eye
* Individuals with choroidal neovascularization from causes other than AMD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT01453920
Study Brief:
Protocol Section:
NCT01453920